Get the latest curated content with The Beat Asia's newsletters. Sign up now for a weekly dose of the best stories, events, and deals delivered straight to your inbox. Don't miss out! Click here to subscribe.
Singapore's first-ever antibody-drug conjugate, EBC-129, has been greenlit by the United States Food and Drug Administration for in-human clinical trials.
The University of Hong Kong (HKU) has been developing a new Hepatitis B drug with the aim of providing patients treatments without the presence of lifelong medication.
The Health Sciences Authority (HSA) announced in a press release that they’re giving interim authorisation for Molnupiravir to be used in mild to moderate COVID-19 cases.
Singapore authorised the use of Pfizer’s first oral tablet, Paxlovid, to treat adult patients with mild to moderate COVID-19 who are at risk of developing severe symptoms